Glycosylation, UDP-galactopyranose mutase GLF
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | yes | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A0A3S5H724
Term | Name | Level | Count |
---|---|---|---|
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006778 | porphyrin-containing compound metabolic process | 5 | 1 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 6 | 1 |
GO:0006783 | heme biosynthetic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0033013 | tetrapyrrole metabolic process | 4 | 1 |
GO:0033014 | tetrapyrrole biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0042168 | heme metabolic process | 3 | 1 |
GO:0042440 | pigment metabolic process | 2 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0046148 | pigment biosynthetic process | 3 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0008767 | UDP-galactopyranose mutase activity | 4 | 7 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016853 | isomerase activity | 2 | 7 |
GO:0016866 | intramolecular transferase activity | 3 | 7 |
GO:0004729 | oxygen-dependent protoporphyrinogen oxidase activity | 5 | 1 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 1 |
GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 4 | 1 |
GO:0070818 | protoporphyrinogen oxidase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.514 |
CLV_PCSK_PC1ET2_1 | 193 | 195 | PF00082 | 0.570 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 384 | 388 | PF00082 | 0.553 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.429 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.392 |
DEG_SPOP_SBC_1 | 302 | 306 | PF00917 | 0.478 |
DOC_ANK_TNKS_1 | 142 | 149 | PF00023 | 0.478 |
DOC_MAPK_FxFP_2 | 205 | 208 | PF00069 | 0.435 |
DOC_MAPK_gen_1 | 185 | 192 | PF00069 | 0.547 |
DOC_MAPK_gen_1 | 404 | 411 | PF00069 | 0.594 |
DOC_MAPK_MEF2A_6 | 160 | 168 | PF00069 | 0.508 |
DOC_MAPK_RevD_3 | 179 | 194 | PF00069 | 0.502 |
DOC_PP4_FxxP_1 | 153 | 156 | PF00568 | 0.429 |
DOC_PP4_FxxP_1 | 205 | 208 | PF00568 | 0.435 |
DOC_USP7_MATH_1 | 259 | 263 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.541 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.580 |
DOC_USP7_UBL2_3 | 218 | 222 | PF12436 | 0.580 |
DOC_WW_Pin1_4 | 288 | 293 | PF00397 | 0.397 |
LIG_14-3-3_CanoR_1 | 384 | 389 | PF00244 | 0.611 |
LIG_14-3-3_CanoR_1 | 484 | 488 | PF00244 | 0.722 |
LIG_Actin_WH2_2 | 14 | 29 | PF00022 | 0.463 |
LIG_Actin_WH2_2 | 368 | 386 | PF00022 | 0.638 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.651 |
LIG_BRCT_BRCA1_1 | 141 | 145 | PF00533 | 0.538 |
LIG_CSL_BTD_1 | 94 | 97 | PF09270 | 0.508 |
LIG_CtBP_PxDLS_1 | 318 | 322 | PF00389 | 0.541 |
LIG_deltaCOP1_diTrp_1 | 195 | 205 | PF00928 | 0.435 |
LIG_deltaCOP1_diTrp_1 | 86 | 95 | PF00928 | 0.459 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.436 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.423 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.524 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.547 |
LIG_FHA_1 | 304 | 310 | PF00498 | 0.426 |
LIG_FHA_1 | 383 | 389 | PF00498 | 0.644 |
LIG_FHA_2 | 372 | 378 | PF00498 | 0.563 |
LIG_FHA_2 | 463 | 469 | PF00498 | 0.610 |
LIG_IRF3_LxIS_1 | 72 | 78 | PF10401 | 0.580 |
LIG_LIR_Apic_2 | 151 | 156 | PF02991 | 0.426 |
LIG_LIR_Apic_2 | 204 | 208 | PF02991 | 0.435 |
LIG_LIR_Gen_1 | 256 | 265 | PF02991 | 0.454 |
LIG_LIR_Gen_1 | 323 | 334 | PF02991 | 0.483 |
LIG_LIR_Gen_1 | 352 | 361 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 397 | 407 | PF02991 | 0.615 |
LIG_LIR_Gen_1 | 64 | 73 | PF02991 | 0.420 |
LIG_LIR_Gen_1 | 78 | 86 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 256 | 260 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 323 | 329 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 340 | 345 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 352 | 358 | PF02991 | 0.514 |
LIG_LIR_Nem_3 | 397 | 402 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 427 | 432 | PF02991 | 0.602 |
LIG_LIR_Nem_3 | 64 | 69 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 78 | 83 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.380 |
LIG_MAD2 | 6 | 14 | PF02301 | 0.485 |
LIG_SH2_CRK | 257 | 261 | PF00017 | 0.455 |
LIG_SH2_CRK | 367 | 371 | PF00017 | 0.523 |
LIG_SH2_NCK_1 | 442 | 446 | PF00017 | 0.558 |
LIG_SH2_STAP1 | 257 | 261 | PF00017 | 0.435 |
LIG_SH2_STAT3 | 98 | 101 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.526 |
LIG_SH2_STAT5 | 328 | 331 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.435 |
LIG_SH3_3 | 467 | 473 | PF00018 | 0.547 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.437 |
LIG_SUMO_SIM_par_1 | 356 | 362 | PF11976 | 0.467 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.530 |
LIG_TYR_ITIM | 255 | 260 | PF00017 | 0.435 |
LIG_TYR_ITIM | 365 | 370 | PF00017 | 0.590 |
LIG_UBA3_1 | 23 | 27 | PF00899 | 0.541 |
LIG_UBA3_1 | 308 | 314 | PF00899 | 0.580 |
MOD_CDK_SPK_2 | 288 | 293 | PF00069 | 0.366 |
MOD_CDK_SPxxK_3 | 288 | 295 | PF00069 | 0.366 |
MOD_CK1_1 | 210 | 216 | PF00069 | 0.534 |
MOD_CK2_1 | 371 | 377 | PF00069 | 0.539 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.740 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.534 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.425 |
MOD_GlcNHglycan | 284 | 287 | PF01048 | 0.596 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.534 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.497 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.509 |
MOD_GSK3_1 | 462 | 469 | PF00069 | 0.587 |
MOD_GSK3_1 | 483 | 490 | PF00069 | 0.667 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.580 |
MOD_N-GLC_1 | 201 | 206 | PF02516 | 0.446 |
MOD_NEK2_1 | 260 | 265 | PF00069 | 0.444 |
MOD_NEK2_1 | 301 | 306 | PF00069 | 0.435 |
MOD_NEK2_1 | 359 | 364 | PF00069 | 0.613 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.451 |
MOD_NEK2_1 | 483 | 488 | PF00069 | 0.726 |
MOD_NEK2_2 | 201 | 206 | PF00069 | 0.435 |
MOD_NEK2_2 | 337 | 342 | PF00069 | 0.459 |
MOD_PIKK_1 | 359 | 365 | PF00454 | 0.592 |
MOD_PIKK_1 | 475 | 481 | PF00454 | 0.542 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.534 |
MOD_PKA_2 | 235 | 241 | PF00069 | 0.463 |
MOD_PKA_2 | 337 | 343 | PF00069 | 0.456 |
MOD_PKA_2 | 483 | 489 | PF00069 | 0.663 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.435 |
MOD_Plk_1 | 201 | 207 | PF00069 | 0.435 |
MOD_Plk_1 | 447 | 453 | PF00069 | 0.478 |
MOD_Plk_1 | 466 | 472 | PF00069 | 0.538 |
MOD_Plk_2-3 | 253 | 259 | PF00069 | 0.478 |
MOD_Plk_4 | 337 | 343 | PF00069 | 0.463 |
MOD_Plk_4 | 371 | 377 | PF00069 | 0.529 |
MOD_Plk_4 | 384 | 390 | PF00069 | 0.481 |
MOD_Plk_4 | 447 | 453 | PF00069 | 0.478 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.435 |
MOD_ProDKin_1 | 288 | 294 | PF00069 | 0.397 |
MOD_SUMO_rev_2 | 2 | 8 | PF00179 | 0.594 |
MOD_SUMO_rev_2 | 44 | 53 | PF00179 | 0.442 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 257 | 260 | PF00928 | 0.419 |
TRG_ENDOCYTIC_2 | 367 | 370 | PF00928 | 0.510 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.419 |
TRG_ER_diArg_1 | 292 | 295 | PF00400 | 0.580 |
TRG_ER_diArg_1 | 434 | 437 | PF00400 | 0.464 |
TRG_Pf-PMV_PEXEL_1 | 295 | 299 | PF00026 | 0.580 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0X8 | Leptomonas seymouri | 75% | 100% |
A0A0S4J0D0 | Bodo saltans | 54% | 100% |
A0A1X0P6P6 | Trypanosomatidae | 58% | 100% |
A0A422NWN4 | Trypanosoma rangeli | 60% | 100% |
A4H9C5 | Leishmania braziliensis | 87% | 100% |
A4HXP6 | Leishmania infantum | 100% | 100% |
E9ARF7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q5EEK0 | Leishmania major | 96% | 100% |
V5BLY6 | Trypanosoma cruzi | 58% | 100% |